-
1 Comment
Inovalon Holdings, Inc is currently in a long term uptrend where the price is trading 28.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.7.
Inovalon Holdings, Inc's total revenue rose by 9.4% to $190M since the same quarter in the previous year.
Its net income has increased by 353.9% to $21M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.6% to $13M since the same quarter in the previous year.
Based on the above factors, Inovalon Holdings, Inc gets an overall score of 4/5.
| Exchange | NYSE ARCA |
|---|---|
| CurrencyCode | USD |
| Beta | 0.53 |
|---|---|
| Market Cap | None |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
The fund invests at least 80% of its net assets in FLexible EXchange® Options that reference the iShares MSCI EAFE ETF. FLEX Options are exchange-traded option contracts with uniquely customizable terms. It's strategy has been specifically designed to produce the outcomes based upon the performance of the underlying ETF"s share price over the duration of the outcome period. The fund is non-diversified.
Here's how to backtest a trading strategy or backtest a portfolio for INOV using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
